ArticleFrontiers in oncology2019

Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance.

Kun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.